NELARABINE

Indications and dose

T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma in children who have relapsed or who are refractory after receiving at least two previous regimens

...

This item requires a subscription.
For full access to this content, log in to an existing user account or purchase an individual subscription.
×
Sign in or create an account
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. Sign in or purchase a subscription to access this content. ×